Quadrant Capital Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-106
| Closed | -$275 | – | 2782 |
|
|
2023
Q2 | $275 | Buy |
106
+26
| +33% | +$67 | ﹤0.01% | 2636 |
|
|
2023
Q1 | $327 | Buy |
+80
| New | +$327 | ﹤0.01% | 2643 |
|
|
2022
Q3 | – | Sell |
-22
| Closed | – | – | 2855 |
|
|
2022
Q2 | $0 | Buy |
+22
| New | – | ﹤0.01% | 2811 |
|
|
2022
Q1 | – | Sell |
-21
| Closed | – | – | 2740 |
|
|
2021
Q4 | $0 | Sell |
21
-4
| -16% | – | ﹤0.01% | 2746 |
|
|
2021
Q3 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 2431 |
|
|
2021
Q2 | – | Sell |
-27
| Closed | -$1K | – | 2610 |
|
|
2021
Q1 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 2331 |
|
|
2020
Q2 | – | Sell |
-42
| Closed | -$1K | – | 2442 |
|
|
2020
Q1 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 2069 |
|